All technology developed internally.
All patents assigned to Endomedix, Inc.
- 5 issued & 1 allowed US patents
- 3 issued Canadian patents
- 1 European patent
- 1 PCT application – Published
Newest US patent (US 10,517,988 B1 and US 16/697,717) & PCT application cover original & newest generation technologies
List of Patents and Patent Applications
US 10,517,988 B1 Methods and Compositions for Achieving Hemostasis and Stable Clot Formation
30 claims
Expiration: December 2038
US 16/697,717 Methods and Compositions for Achieving Hemostasis and Stable Clot Formation
32 claims ; Notice of allowance – March 10th, 2021
Expiration: December 2038
PCT Application Methods and Compositions for Achieving Hemostasis and Stable Clot Formation
WO 2020/106703 A1 105 claims
Published: May 28, 2020
US 7,854,923 B2 Biopolymer System for Tissue Sealing
16 claims
Expiration: December 2026
US 9,259,434 B2 Biopolymer System for Tissue Sealing
7 claims
Expiration: April 2026
US 8,513,217 B2 Biopolymer System for Tissue Sealing
21 claims
Expiration: April 2027
US 9,731,044 B2 Biopolymer System for Tissue Sealing
23 claims
Expiration: May 2027
CA 2,686,132 Biopolymer System for Tissue Sealing
83 claims
Expiration: February 2027
CA 2,808,235 Biopolymer System for Tissue Sealing
74 claims
Expiration: February 2027
CA 2,858,696 Biopolymer System for Tissue Sealing
74 claims
Expiration: February 2027
EP 2,013,237 B1 Biopolymer System for Tissue Sealing
13 claims
Expiration: February 2027
Note: Validated in France, Germany, Switzerland and Great Britain